Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus V Heppt

Showing results (131-140 of 169) with videos related to

Pageof 17
Sort By:
JMIR Public Health and Surveillance|July 20, 2018
Facial-Aging Mobile Apps for Smoking Prevention in Secondary Schools in Brazil: Appearance-Focused Interventional StudyBreno Bernardes-Souza, Francisco Patruz Ananias De Assis Pires, Gustavo Moreira Madeira, et al.
European Journal of Cancer (Oxford, England : 1990)|June 11, 2017
Prognostic factors and treatment outcomes in 444 patients with mucosal melanomaMarkus V Heppt, Alexander Roesch, Benjamin Weide, et al.
European Journal of Cancer (Oxford, England : 1990)|January 10, 2021
Robustness of convolutional neural networks in recognition of pigmented skin lesionsRoman C Maron, Sarah Haggenmüller, Christof von Kalle, et al.
International Journal of Cancer|July 8, 2024
Influence of adjuvant therapies on organ-specific recurrence of cutaneous melanoma: A multicenter study on 1383 patients of the prospective DeCOG registry ADORegSebastian A Wohlfeil, Leonie Kranzmann, Christel Weiß, et al.
Journal of Clinical Medicine|May 16, 2020
Treatment Motivations and Expectations in Patients with Actinic Keratosis: A German-Wide Multicenter, Cross-Sectional TrialTheresa Steeb, Anja Wessely, Dagmar von Bubnoff, et al.
Frontiers in Medicine|May 22, 2020
Effects of Label Noise on Deep Learning-Based Skin Cancer ClassificationAchim Hekler, Jakob N Kather, Eva Krieghoff-Henning, et al.
European Journal of Cancer (Oxford, England : 1990)|June 27, 2017
Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibitionMarkus V Heppt, Lucie Heinzerling, Katharina C Kähler, et al.
Frontiers of Medicine|July 11, 2023
Liver-directed treatment is associated with improved survival and increased response to immune checkpoint blockade in metastatic uveal melanoma: results from a retrospective multicenter trialElias A T Koch, Anne Petzold, Anja Wessely, et al.
Frontiers in Immunology|June 25, 2024
Optimizing immune checkpoint blockade in metastatic uveal melanoma: exploring the association of overall survival and the occurrence of adverse eventsElias A T Koch, Anne Petzold, Edgar Dippel, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 30, 2026
Role of comorbidities and medication on immunotherapy efficacy in cSCC: A DeCOG multicentre analysisGlenn Geidel, Sabrina Bänsch, Laura Adam, et al.
Pageof 17

Showing results (131-140 of 169) with videos related to

Sort By:
Pageof 17
JMIR Public Health and Surveillance|July 20, 2018
Facial-Aging Mobile Apps for Smoking Prevention in Secondary Schools in Brazil: Appearance-Focused Interventional StudyBreno Bernardes-Souza, Francisco Patruz Ananias De Assis Pires, Gustavo Moreira Madeira, et al.
European Journal of Cancer (Oxford, England : 1990)|June 11, 2017
Prognostic factors and treatment outcomes in 444 patients with mucosal melanomaMarkus V Heppt, Alexander Roesch, Benjamin Weide, et al.
European Journal of Cancer (Oxford, England : 1990)|January 10, 2021
Robustness of convolutional neural networks in recognition of pigmented skin lesionsRoman C Maron, Sarah Haggenmüller, Christof von Kalle, et al.
International Journal of Cancer|July 8, 2024
Influence of adjuvant therapies on organ-specific recurrence of cutaneous melanoma: A multicenter study on 1383 patients of the prospective DeCOG registry ADORegSebastian A Wohlfeil, Leonie Kranzmann, Christel Weiß, et al.
Journal of Clinical Medicine|May 16, 2020
Treatment Motivations and Expectations in Patients with Actinic Keratosis: A German-Wide Multicenter, Cross-Sectional TrialTheresa Steeb, Anja Wessely, Dagmar von Bubnoff, et al.
Frontiers in Medicine|May 22, 2020
Effects of Label Noise on Deep Learning-Based Skin Cancer ClassificationAchim Hekler, Jakob N Kather, Eva Krieghoff-Henning, et al.
European Journal of Cancer (Oxford, England : 1990)|June 27, 2017
Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibitionMarkus V Heppt, Lucie Heinzerling, Katharina C Kähler, et al.
Frontiers of Medicine|July 11, 2023
Liver-directed treatment is associated with improved survival and increased response to immune checkpoint blockade in metastatic uveal melanoma: results from a retrospective multicenter trialElias A T Koch, Anne Petzold, Anja Wessely, et al.
Frontiers in Immunology|June 25, 2024
Optimizing immune checkpoint blockade in metastatic uveal melanoma: exploring the association of overall survival and the occurrence of adverse eventsElias A T Koch, Anne Petzold, Edgar Dippel, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|January 30, 2026
Role of comorbidities and medication on immunotherapy efficacy in cSCC: A DeCOG multicentre analysisGlenn Geidel, Sabrina Bänsch, Laura Adam, et al.
Pageof 17